$SBH
Sally Beauty Holdings, Inc.

2023 Q1 Form 10-Q Financial Statement

#000156459023001405 Filed on February 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2021 Q4
Revenue $918.7M $957.1M $980.3M
YoY Change 0.8% -2.37% 4.73%
Cost Of Revenue $450.4M $468.5M $480.1M
YoY Change 0.97% -2.42% 3.19%
Gross Profit $468.3M $488.6M $500.1M
YoY Change 0.65% -2.31% 6.25%
Gross Profit Margin 50.98% 51.05% 51.02%
Selling, General & Admin $389.7M $391.6M $386.3M
YoY Change 2.85% 1.38% 5.48%
% of Gross Profit 83.2% 80.15% 77.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $25.06M $25.29M $24.42M
YoY Change 4.21% 3.54% -7.45%
% of Gross Profit 5.35% 5.18% 4.88%
Operating Expenses $389.7M $391.6M $386.3M
YoY Change 2.85% 1.38% 5.48%
Operating Profit $71.41M $86.59M $112.8M
YoY Change -17.41% -23.22% 8.11%
Interest Expense $16.69M $17.92M -$20.24M
YoY Change -183.86% -188.55% -22.08%
% of Operating Profit 23.37% 20.7% -17.95%
Other Income/Expense, Net
YoY Change
Pretax Income $54.72M $68.67M $92.54M
YoY Change -17.79% -25.8% 18.12%
Income Tax $13.86M $18.33M $23.70M
% Of Pretax Income 25.33% 26.69% 25.61%
Net Earnings $40.86M $50.34M $68.84M
YoY Change -12.71% -26.88% 20.37%
Net Earnings / Revenue 4.45% 5.26% 7.02%
Basic Earnings Per Share $0.38 $0.47 $0.61
Diluted Earnings Per Share $0.37 $0.46 $604.0K
COMMON SHARES
Basic Shares Outstanding 107.3M 107.0M 112.0M
Diluted Shares Outstanding 109.7M 109.5M 114.0M

Balance Sheet

Concept 2023 Q1 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $61.62M $99.07M $298.1M
YoY Change -72.9% -66.77% -44.54%
Cash & Equivalents $61.62M $99.07M $298.1M
Short-Term Investments
Other Short-Term Assets $48.07M $57.84M $45.40M
YoY Change -5.72% 27.41% 2.47%
Inventory $1.024B $986.9M $1.006B
Prepaid Expenses
Receivables $30.54M $32.67M $29.59M
Other Receivables $45.12M $42.74M $36.57M
Total Short-Term Assets $1.209B $1.219B $1.416B
YoY Change -7.12% -13.87% -8.43%
LONG-TERM ASSETS
Property, Plant & Equipment $283.4M $288.7M $825.5M
YoY Change -65.81% -65.02% 0.04%
Goodwill $534.2M $532.5M
YoY Change
Intangibles $50.53M $50.96M
YoY Change
Long-Term Investments
YoY Change
Other Assets $35.66M $34.33M $20.28M
YoY Change 78.39% 69.27% -14.43%
Total Long-Term Assets $1.466B $1.449B $1.440B
YoY Change 1.72% 0.62% -0.91%
TOTAL ASSETS
Total Short-Term Assets $1.209B $1.219B $1.416B
Total Long-Term Assets $1.466B $1.449B $1.440B
Total Assets $2.675B $2.669B $2.856B
YoY Change -2.47% -6.56% -4.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $265.1M $296.2M $346.3M
YoY Change 10.18% -14.48% 21.25%
Accrued Expenses $168.2M $142.8M $151.9M
YoY Change -1.38% -6.02% -46.84%
Deferred Revenue $14.42M $15.26M $19.08M
YoY Change -13.37% -20.0% 17.9%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $38.18M $65.17M $184.0K
YoY Change 20875.27% 35319.02% -8.0%
Total Short-Term Liabilities $630.6M $677.3M $681.8M
YoY Change 9.82% -0.66% 15.49%
LONG-TERM LIABILITIES
Long-Term Debt $1.065B $1.082B $1.382B
YoY Change -22.87% -21.69% -23.15%
Other Long-Term Liabilities $22.04M $22.75M $423.6M
YoY Change -94.79% -94.63% 0.79%
Total Long-Term Liabilities $22.04M $22.75M $1.806B
YoY Change -98.78% -98.74% -18.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $630.6M $677.3M $681.8M
Total Long-Term Liabilities $22.04M $22.75M $1.806B
Total Liabilities $2.249B $2.295B $2.575B
YoY Change -8.98% -10.86% -11.23%
SHAREHOLDERS EQUITY
Retained Earnings $531.4M $490.5M
YoY Change
Common Stock $14.87M $9.402M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $425.9M $373.3M $281.0M
YoY Change
Total Liabilities & Shareholders Equity $2.675B $2.669B $2.856B
YoY Change -2.47% -6.56% -4.79%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income $40.86M $50.34M $68.84M
YoY Change -12.71% -26.88% 20.37%
Depreciation, Depletion And Amortization $25.06M $25.29M $24.42M
YoY Change 4.21% 3.54% -7.45%
Cash From Operating Activities $24.70M $54.95M -$5.685M
YoY Change 748.11% -1066.6% -114.58%
INVESTING ACTIVITIES
Capital Expenditures $17.17M $25.01M $26.39M
YoY Change -196.92% -5.24% 70.45%
Acquisitions $319.0K
YoY Change -84.25%
Other Investing Activities $0.00 $0.00 -$319.0K
YoY Change -100.0% -100.0% -84.05%
Cash From Investing Activities -$17.17M -$25.01M -$26.71M
YoY Change -3.07% -6.37% 52.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $75.00M
YoY Change
Debt Paid & Issued, Net $233.9M $1.421M
YoY Change 16362.14% 2155.56%
Cash From Financing Activities -43.25M -5.992M -70.19M
YoY Change -23.24% -91.46% 22395.19%
NET CHANGE
Cash From Operating Activities 24.70M 54.95M -5.685M
Cash From Investing Activities -17.17M -25.01M -26.71M
Cash From Financing Activities -43.25M -5.992M -70.19M
Net Change In Cash -35.72M 28.51M -102.6M
YoY Change -49.79% -127.8% -584.64%
FREE CASH FLOW
Cash From Operating Activities $24.70M $54.95M -$5.685M
Capital Expenditures $17.17M $25.01M $26.39M
Free Cash Flow $7.523M $29.94M -$32.08M
YoY Change -63.54% -193.36% -236.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18328000
CY2021Q4 sbh Deferred Income Tax Expense Benefit Operating Activities
DeferredIncomeTaxExpenseBenefitOperatingActivities
1867000
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2270000
CY2021Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2841000
CY2022Q4 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
3817000
CY2021Q4 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1724000
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
38019000
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
468481000
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
480122000
CY2022Q4 us-gaap Gross Profit
GrossProfit
488574000
CY2021Q4 us-gaap Gross Profit
GrossProfit
500129000
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
391580000
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
386250000
CY2022Q4 us-gaap Restructuring Charges
RestructuringCharges
10406000
CY2021Q4 us-gaap Restructuring Charges
RestructuringCharges
1099000
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
86588000
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
112780000
CY2022Q4 us-gaap Interest Expense
InterestExpense
17923000
CY2021Q4 us-gaap Interest Expense
InterestExpense
20241000
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
68665000
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
92539000
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23701000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
50337000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
68838000
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2021Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
137326000
CY2022Q4 sbh Deferred Income Tax Expense Benefit Operating Activities
DeferredIncomeTaxExpenseBenefitOperatingActivities
889000
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107140000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111995000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109460000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113968000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
50337000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
68838000
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
25941000
CY2021Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4509000
CY2022Q4 sbh Other Comprehensive Income Loss Interest Rate Caps Net Of Tax
OtherComprehensiveIncomeLossInterestRateCapsNetOfTax
203000
CY2021Q4 sbh Other Comprehensive Income Loss Interest Rate Caps Net Of Tax
OtherComprehensiveIncomeLossInterestRateCapsNetOfTax
278000
CY2022Q4 sbh Other Comprehensive Income Loss Foreign Exchange Contracts Net Of Tax
OtherComprehensiveIncomeLossForeignExchangeContractsNetOfTax
-910000
CY2021Q4 sbh Other Comprehensive Income Loss Foreign Exchange Contracts Net Of Tax
OtherComprehensiveIncomeLossForeignExchangeContractsNetOfTax
480000
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
25234000
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3751000
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
75571000
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
65087000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
293636000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
50337000
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
25234000
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5135000
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
82000
CY2022Q4 sbh Shares Paid For Tax Withholding For Share Based Compensation Value
SharesPaidForTaxWithholdingForShareBasedCompensationValue
-1126000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
373298000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
280741000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
68838000
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3751000
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3958000
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7372000
CY2021Q4 sbh Shares Paid For Tax Withholding For Share Based Compensation Value
SharesPaidForTaxWithholdingForShareBasedCompensationValue
-1137000
CY2021Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-75000000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
281021000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
50337000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
68838000
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25285000
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24421000
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
5135000
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
3958000
CY2022Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
648000
CY2021Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
932000
CY2022Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
2103000
CY2022Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-77000
CY2021Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3000
CY2022Q4 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
4018000
CY2021Q4 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
446000
CY2022Q4 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-4074000
CY2021Q4 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1371000
CY2022Q4 sbh Increase Decrease In Operating Lease Assets And Liabilities
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities
-10392000
CY2021Q4 sbh Increase Decrease In Operating Lease Assets And Liabilities
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities
6475000
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7606000
CY2021Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
16729000
CY2022Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
12460000
CY2021Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
18166000
CY2022Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
313000
CY2021Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-11790000
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
54951000
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5685000
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25007000
CY2021Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26390000
CY2021Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
319000
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25007000
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26709000
CY2022Q4 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
229000000
CY2022Q4 sbh Repayments Of Long Term Debt Including Prepayment Costs
RepaymentsOfLongTermDebtIncludingPrepaymentCosts
233927000
CY2021Q4 sbh Repayments Of Long Term Debt Including Prepayment Costs
RepaymentsOfLongTermDebtIncludingPrepaymentCosts
1421000
CY2021Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
75000000
CY2022Q4 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
60000
CY2021Q4 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
7372000
CY2022Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1125000
CY2021Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1136000
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5992000
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-70185000
CY2022Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4561000
CY2021Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-240000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
28513000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-102819000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
70558000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
400959000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
99071000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
298140000
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
26758000
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
35034000
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3081000
CY2021Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3978000
CY2022Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5542000
CY2021Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3594000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19077000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1086086000
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1056350000
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
1087461000
CY2022Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1037494000
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
4266000
CY2022Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
4161000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3865000
CY2022Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In order to present our financial statements in conformity with GAAP, we are required to make certain estimates and assumptions that impact our interim financial statements and supplementary disclosures. These estimates may use forecasted financial information based on reasonable information available, however are subject to change in the future. Significant estimates and assumptions are part of our accounting for sales allowances, deferred revenue, valuation of inventory, amortization and depreciation, intangibles and goodwill, and other reserves. We believe these estimates and assumptions are reasonable; however, they are based on management’s current knowledge of events and actions, and changes in facts and circumstances may result in revised estimates and impact actual results.</p>
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
13460000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16744000
CY2022Q4 sbh Contract With Customer Liability Loyalty Points And Gift Cards Issued But Not Redeemed Net Of Estimated Breakage
ContractWithCustomerLiabilityLoyaltyPointsAndGiftCardsIssuedButNotRedeemedNetOfEstimatedBreakage
6291000
CY2021Q4 sbh Contract With Customer Liability Loyalty Points And Gift Cards Issued But Not Redeemed Net Of Estimated Breakage
ContractWithCustomerLiabilityLoyaltyPointsAndGiftCardsIssuedButNotRedeemedNetOfEstimatedBreakage
5842000
CY2022Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-4489000
CY2021Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-3509000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
15262000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107140000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111995000
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2320000
CY2021Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1973000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109460000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113968000
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2123000
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2775000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
58693000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
20384000
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
18810000
CY2022Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
14353000
CY2022Q3 us-gaap Accrued Rent Current
AccruedRentCurrent
10701000
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
6104000
CY2022Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
5742000
CY2022Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q4 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2021Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q4 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1008000
CY2021Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1071000
CY2022Q4 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
6400000
CY2022Q4 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
1700000
CY2021Q4 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
900000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
46027000
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
13445000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
47786000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
49513000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
142785000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
161065000
CY2022Q4 us-gaap Derivative Number Of Instruments Held
DerivativeNumberOfInstrumentsHeld
0
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
957055000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
980251000
CY2022Q4 us-gaap Restructuring Charges
RestructuringCharges
10406000
CY2021Q4 us-gaap Restructuring Charges
RestructuringCharges
1099000
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
86588000
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
112780000
CY2022Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-17923000
CY2021Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-20241000
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
68665000
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
92539000
CY2022Q4 sbh Restructuring Expense
RestructuringExpense
10406000
CY2021Q4 sbh Restructuring Expense
RestructuringExpense
1099000
CY2022Q4 sbh Restructuring Gain And Expenses
RestructuringGainAndExpenses
7726000
CY2021Q4 sbh Restructuring Gain And Expenses
RestructuringGainAndExpenses
1099000

Files In Submission

Name View Source Status
0001564590-23-001405-index-headers.html Edgar Link pending
0001564590-23-001405-index.html Edgar Link pending
0001564590-23-001405.txt Edgar Link pending
0001564590-23-001405-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
sbh-20221231_def.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sbh-10q_20221231.htm Edgar Link pending
sbh-20221231.xsd Edgar Link pending
sbh-ex22_11.htm Edgar Link pending
sbh-20221231_lab.xml Edgar Link unprocessable
sbh-20221231_pre.xml Edgar Link unprocessable
sbh-ex311_9.htm Edgar Link pending
sbh-ex312_8.htm Edgar Link pending
sbh-ex321_7.htm Edgar Link pending
sbh-ex322_10.htm Edgar Link pending
Show.js Edgar Link pending
sbh-20221231_cal.xml Edgar Link unprocessable
sbh-10q_20221231_htm.xml Edgar Link completed